Mereo BioPharma Group PLC 2021 Annual Report
Company: Mereo BioPharma Group PLC
Sector: Manufacturing
Country: United Kingdom
Year: 2021
Type: Annual Report
Pages: 98
The report highlights the Group's £36.5 million revenue from the Ultragenyx licensing arrangement in 2021. It describes a lean workforce and reports 68,626 KWH of energy use with 15 tCO2e of associated emissions, stating that the Group only had Scope 2 emissions. The report also describes office refurbishment measures including insulation, motion-activated lighting and heating-system changes.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.